NO951691L - Kalsiumkanal-blokkerende polypeptider fra Theraphosidal aphonopelma - Google Patents

Kalsiumkanal-blokkerende polypeptider fra Theraphosidal aphonopelma

Info

Publication number
NO951691L
NO951691L NO951691A NO951691A NO951691L NO 951691 L NO951691 L NO 951691L NO 951691 A NO951691 A NO 951691A NO 951691 A NO951691 A NO 951691A NO 951691 L NO951691 L NO 951691L
Authority
NO
Norway
Prior art keywords
aphonopelma
calcium channel
theraphosidal
channel blocking
blocking polypeptides
Prior art date
Application number
NO951691A
Other languages
English (en)
Norwegian (no)
Other versions
NO951691D0 (no
Inventor
Robert A Volkmann
Nicholas Alex Saccomano
Ii Deane M Nason
Douglas Phillips
Original Assignee
Pfizer
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Nps Pharma Inc filed Critical Pfizer
Publication of NO951691D0 publication Critical patent/NO951691D0/no
Publication of NO951691L publication Critical patent/NO951691L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO951691A 1992-11-03 1995-05-02 Kalsiumkanal-blokkerende polypeptider fra Theraphosidal aphonopelma NO951691L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97332392A 1992-11-03 1992-11-03
PCT/US1993/009069 WO1994010196A1 (en) 1992-11-03 1993-09-28 Calcium channel blocking polypeptides from theraphosidae aphonopelma

Publications (2)

Publication Number Publication Date
NO951691D0 NO951691D0 (no) 1995-05-02
NO951691L true NO951691L (no) 1995-05-02

Family

ID=25520754

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951691A NO951691L (no) 1992-11-03 1995-05-02 Kalsiumkanal-blokkerende polypeptider fra Theraphosidal aphonopelma

Country Status (21)

Country Link
EP (1) EP0668872B1 (cs)
JP (1) JP2667578B2 (cs)
KR (1) KR950704352A (cs)
CN (1) CN1033330C (cs)
AT (1) ATE166067T1 (cs)
AU (1) AU668430B2 (cs)
BR (1) BR9307363A (cs)
CA (1) CA2148504A1 (cs)
CZ (1) CZ283548B6 (cs)
DE (1) DE69318567T2 (cs)
DK (1) DK0668872T3 (cs)
FI (1) FI934847A7 (cs)
HU (1) HUT66075A (cs)
IL (1) IL107434A0 (cs)
NO (1) NO951691L (cs)
NZ (1) NZ256767A (cs)
PL (1) PL308668A1 (cs)
RU (1) RU2120945C1 (cs)
TW (1) TW272196B (cs)
WO (1) WO1994010196A1 (cs)
ZA (1) ZA938165B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624288B1 (en) * 1997-12-16 2003-09-23 Cognetix, Inc. Gamma-conopeptides
AU2012300197B2 (en) * 2011-08-24 2018-01-18 The University Of Queensland Pest-controlling agents isolated from spider venom and uses thereof
CZ202251A3 (cs) * 2022-02-02 2023-04-12 Ego 93 S.R.O. Senzibilační roztok a způsob jeho přípravy

Also Published As

Publication number Publication date
ZA938165B (en) 1995-05-02
DE69318567D1 (de) 1998-06-18
RU95109941A (ru) 1997-01-10
PL308668A1 (en) 1995-08-21
FI934847L (fi) 1994-05-04
NZ256767A (en) 1996-10-28
NO951691D0 (no) 1995-05-02
CN1090289A (zh) 1994-08-03
CZ283548B6 (cs) 1998-04-15
KR950704352A (ko) 1995-11-20
EP0668872B1 (en) 1998-05-13
DE69318567T2 (de) 1998-09-10
AU5164293A (en) 1994-05-24
DK0668872T3 (da) 1998-10-07
CZ112695A3 (en) 1995-11-15
HUT66075A (en) 1994-09-28
AU668430B2 (en) 1996-05-02
WO1994010196A1 (en) 1994-05-11
CA2148504A1 (en) 1994-05-11
FI934847A7 (fi) 1994-05-04
TW272196B (cs) 1996-03-11
CN1033330C (zh) 1996-11-20
EP0668872A1 (en) 1995-08-30
JP2667578B2 (ja) 1997-10-27
RU2120945C1 (ru) 1998-10-27
BR9307363A (pt) 1999-05-11
JPH07508758A (ja) 1995-09-28
FI934847A0 (fi) 1993-11-02
IL107434A0 (en) 1994-01-25
ATE166067T1 (de) 1998-05-15

Similar Documents

Publication Publication Date Title
AU594488B2 (en) Agents for the treatment of arthroses
NZ333725A (en) Keratinocyte growth factor-2 (KGF-2) deletion mutants
NO965362L (no) Syntetiske lederpeptidsekvenser
DK0720482T3 (da) Prosaposin og cytokin-afledte peptider som terapeutiske midler
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
DK0778890T3 (da) DNA, som koder for en human calciumkanal-alpha-1E-underenhed
FI933349A0 (fi) Kalsiumkanaler blockerande polypeptid fraon agelonopsis aperta
NO944417L (no) Kalsium kanalblokkerende polypeptider fra Filistata hibernalis
PL308668A1 (en) Peptides capable to block calcareous channels with theraphosidae aphonoplema
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
TR199802387T2 (xx) Do�um kontrol� i�in kullan�lan Zona Pellucida proteinleri.
NO950293L (no) Kalsiumkanalblokkerende polypeptid fra Agelenopsis aperta
UA10750A (uk) Склад для лікуваhhя виразкової хвороби шлуhка та дваhадцятипалої кишки "дипромак"
DE59405189D1 (de) Neues diphenylhexen
EP0374909A3 (de) Für das Plazentaprotein 11 (PP11) kodierende cDNA, ihre Isolierung und Verwendung